# Chemsex Health Evaluation With Extended Release System for HIV Treatment

> **NCT06565013** · — · NOT_YET_RECRUITING · sponsor: **Clinique Médicale L'Actuel** · enrollment: 50 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Cabenuva 600/900
- **OTHER:** Self administered questionnaires
- **OTHER:** Semi-directed interview

## Key facts

- **NCT ID:** NCT06565013
- **Lead sponsor:** Clinique Médicale L'Actuel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565013, "Chemsex Health Evaluation With Extended Release System for HIV Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06565013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*